The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast... by Rie Sugihara, Hidetaka Watanabe, Shuntaro Matsushima, Yuriko Katagiri, Shuko Saku, Mina Okabe, Yuko Takao, Nobutaka Iwakuma, Etsuyo Ogo, Fumihiko Fujita, Uhi Toh

Get full text